Protagonist: should we eradicate Helicobacter pylori in non-ulcer dyspepsia?
McColl
K E
KE
Department of Medicine and Therapeutics, Gardiner Institute, Western Infirmary, Glasgow G11 6NT, UK. K.E.McColl@clinmed.gla.ac.uk
D000863:Antacids / Q000191:economics / Q000627:therapeutic use; D003362:Cost-Benefit Analysis; D004415:Dyspepsia / Q000188:drug therapy / Q000191:economics / Q000382:microbiology*; D016481:Helicobacter Infections / Q000150:complications / Q000188:drug therapy* / Q000191:economics; D016480:Helicobacter pylori; D006801:Humans; D010437:Peptic Ulcer / Q000517:prevention & control; D016032:Randomized Controlled Trials as Topic; D016896:Treatment Outcome
D000863:Antacids